| So Urgent I Recorded This From My House | Marc Lichtenfeld, Chief Income Strategist, The Oxford Club | More data is expected THIS WEEK on the drug "leading the race to the cure for the coronavirus"... The company behind it is poised to "upend [the] market with its first COVID-19 study data," Bloomberg reports. And if the results of the study are positive... This company could take off like a rocket. That's why I recorded this video for you from my home. You need to know everything about this situation right now. Because if this company is successful, investing in it now could make your retirement - no joke. Sincerely, Marc P.S. Reuters reports that this company's "coronavirus treatment [is] running ahead of schedule." In other words, you don't have time to waste. | | | | | |
No comments:
Post a Comment